Loading…
Fair Balance Prescription Drug Advertisement Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2008 · fourth_quarter · Taxation/Internal Revenue Code
Bills with similar content found using semantic analysis.
Sources: Congress.gov
S. 334 and H.R. 3163, Healthy Americans Act, provisions regarding a disallowance of the tax deductibility of prescription drug advertising S. 1342 and H.R. 2633, Healthy Lifestyles and Prevention America Act (HeLP America Act), provisions regarding the disallowance of the tax deductibility of tobacco advertising H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, provisions relating to a disallowance of the tax deductibility of prescription drug advertising
Client expense: $260,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R. 2900, Food and Drug Administration Amendments Act of 2007; H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S. 1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Taxation/Internal Revenue Code
S. 334 and H.R. 3163, Healthy Americans Act, provisions regarding a disallowance of the tax deductibility of prescription drug advertising S. 1342 and H.R. 2633, Healthy Lifestyles and Prevention America Act (HeLP America Act), provisions regarding the disallowance of the tax deductibility of tobacco advertising H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, provisions relating to a disallowance of the tax deductibility of prescription drug advertising
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
H.R. 1424, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (as included in the Emergency Economic Stabilization Act of 2008), provisions on mental health parity and physician-owned hospitals H.R. 6983, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, all provisions S. 558 Mental Health Parity Act of 2007, all provisions S. 3335, Jobs, Energy, Families, and Disaster Relief Act of 2008, provisions on mental health parity H.R. 6049, Energy and Tax Extenders Act of 2008, provisions on mental health parity H.R. 6357, PRO(TECH)T Act of 2008, all provisions H.R. 6898, Health-e Information Technology Act of 2008, all provisions S. 1693, Wired for Health Care Quality Act, provisions relating to data collection, quality, and performance reporting H.R. 6179, Promoting Health Information Technology Act of 2008, all provisions S. 3300, Rural Hospital Assistance Act of 2008, provisions on physician-owned hospitals and self-referral S. 334, Healthy Americans Act, all provisions H.R. 6569, Public Health Emergency Response Act of 2008, all provisions H.R. 1841, AmeriCare Health Care Act of 2007, all provisions H.R. 2357, MediKids Health Insurance Act of 2007, all provisions H.R. 5873, Family Leave Insurance Act of 2008, all provisions H.R. 5639, Physical Activity Guidelines for Americans Act of 2008, all provisions H.R. 3257, Fitness Integrated with Teaching Kids Act, all provisions S. 3575, Labeling Education and Nutrition Act of 2008 (LEAN Act of 2008), all provisions H.R. 2833, Preexisting Condition Exclusion Patient Protection Act of 2007, all provisions H.R. 2842, Children's Health Protection Act of 2007, all provisions H.R. 6845, Fair Copyright in Research Works Act, all provisions H.R. 3544, Catalyst to Better Diabetes Care Act of 2007, all provisions H.R. 1532, Comprehensive Tuberculosis Elimination Act of 2007, all provisions H.R. 2994, National Pain Care Policy Act of 2007, all provisions H.R. 1283, Arthritis Prevention, Control, and Cure Act of 2007, all provisions S. 2731, to improve the oversight and regulation of tissue banks and the tissue donation process, and for other purposes, all provisions S. 3040 and H.R. 6100, Kid-Safe Chemicals Act of 2008, all provisions H.R. 2464, to amend the Public Health Service Act to provide a means for continued improvement in emergency medical services for children, all provisions H.R. 7192, Preserving Patient Access to Primary Care Act, all provisions H.R. 758, Breast Cancer Patient Protection Act of 2008, all provisions S. 3354, Volunteer Healthcare Program Act of 2008, all provisions S. 3408, Comparative Effectiveness Research Act of 2008, all provisions H.R. 6752 and S. 3396, Independent Drug Education and Outreach Act of 2008, all provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, all provisions H.R. 5620, Fresh Produce Safety Act, all provisions H.R. 1038 and S. 623, to amend the Public Health Service Act to provide for the licensing of comparable and interchangeable biological products, and for other purposes, all provisions H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, all provisions S. 1505, Affordable Biologics for Consumers Act, all provisions H.R. 6498 and S. 976, Genomics and Personalized Medicine Act of 2008, all provisions H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, all provisions Health Disparities Inclusion of Minorities in Clinical Trials Health Savings Accounts Medical devices - standardization of expiration dates Disability Nondiscrimination (Americans with Disabilities Act/hearing interpreters) The Uninsured, AMA's Plan Childhood Obesity Social Security Administration Disability Claims Processing Blood and Blood Components Safety Pregnancy and Lactation Prescription Drug and Biological Products Labeling Children's Health Insurance Program Directive Post-marketing Surveillance of Prescription Drugs DEA - E-Prescribing Constraints E-Prescribing Incentive Program Provider Conscience Clause Home Stockpiling of Antivirals National Ambient Air Quality for Lead
Client expense: $4,260,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), SENATE, Social Security Administration (SSA)
2008 · third_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R. 2900, Food and Drug Administration Amendments Act of 2007; H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S. 1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R. 2900, Food and Drug Administration Amendments Act of 2007; H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S. 1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Taxation/Internal Revenue Code
S. 334 and H.R. 3163, Healthy Americans Act, provisions regarding a disallowance of the tax deductibility of prescription drug advertising S. 1342 and H.R. 2633, Healthy Lifestyles and Prevention America Act (HeLP America Act), provisions regarding the disallowance of the tax deductibility of tobacco advertising H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, provisions relating to a disallowance of the tax deductibility of prescription drug advertising
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Taxation/Internal Revenue Code
S. 334 and H.R. 3163, Healthy Americans Act, provisions regarding a disallowance of the tax deductibility of prescription drug advertising S. 1342 and H.R. 2633, Healthy Lifestyles and Prevention America Act (HeLP America Act), provisions regarding the disallowance of the tax deductibility of tobacco advertising H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007, provisions relating to a disallowance of the tax deductibility of prescription drug advertising
Client expense: $250,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007
Client expense: Not reported · Firm income: $10,000
2008 · first_quarter · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R. 2900, Food and Drug Administration Amendments Act of 2007; H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S. 1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Taxation/Internal Revenue Code
H.R. 2823 - Fair Balance Prescription Drug Advertisement Act of 2007 (prescription drug advertising) Proposals to end the tax deductibility for certain categories of advertising expenditures S. 334 - Healthy Americans Act (prescription drug advertising) S. 1342 - Healthy Lifestyles and Prevention America Act (HeLP America Act) (tobacco advertising) H.R. 2633 - Healthy Lifestyles and Prevention America Act (HeLP America Act) (tobacco advertising)
Client expense: $480,000 · Firm income: Not reported
Government targets: Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R.2900, Food and Drug Administration Amendments Act of 2007; H.R.2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S.1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Health Issues
S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $40,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · year_end · Advertising
S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 1082 Food and Drug Administration Revitalization Act 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; H.R. 2823 Fair and Balanced Prescription Drug Advertisement Act of 2007; H.R. 2900 Food and Drug Administration Amendments Act of 2007; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
2007 · mid_year · Advertising
Followed progress on all potential Direct to Consumer advertising amendments in the House and Senate, in particular H.R. 2900, Food and Drug Administration Amendments Act of 2007; H.R. 2823, Fair Balance Prescription Drug Advertisement Act of 2007; and S. 1082, FDA Authorization Revitalization Act.
Client expense: Not reported · Firm income: $60,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2007 · mid_year · Taxation/Internal Revenue Code
H.R. 2823 - Fair Balance Prescription Drug Advertisement Act of 2007 (prescription drug advertising) Proposals to end the tax deductibility for certain categories of advertising expenditures S. 334 - Healthy Americans Act (prescription drug advertising) S. 1342 - Healthy Lifestyles and Prevention America Act (HeLP America Act) (tobacco advertising) H.R. 2633 - Healthy Lifestyles and Prevention America Act (HeLP America Act) (tobacco advertising)
Client expense: $460,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE